Cardlytics (CDLX) EPS (Weighted Average and Diluted) (2017 - 2026)
Cardlytics filings provide 9 years of EPS (Weighted Average and Diluted) readings, the most recent being -$0.25 for Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) fell 25.0% to -$0.25 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.93 through Mar 2026, up 43.9% year-over-year, with the annual reading at -$1.95 for FY2025, 50.13% up from the prior year.
- EPS (Weighted Average and Diluted) hit -$0.25 in Q1 2026 for Cardlytics, down from -$0.14 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.91 in Q1 2022 and bottomed at -$11.32 in Q4 2022.
- Average EPS (Weighted Average and Diluted) over 5 years is -$1.38, with a median of -$0.25 recorded in 2024.
- The largest annual shift saw EPS (Weighted Average and Diluted) skyrocketed 207.06% in 2022 before it plummeted 431.58% in 2023.
- Cardlytics' EPS (Weighted Average and Diluted) stood at -$11.32 in 2022, then skyrocketed by 75.8% to -$2.74 in 2023, then soared by 90.88% to -$0.25 in 2024, then surged by 44.0% to -$0.14 in 2025, then tumbled by 78.57% to -$0.25 in 2026.
- Per Business Quant, the three most recent readings for CDLX's EPS (Weighted Average and Diluted) are -$0.25 (Q1 2026), -$0.14 (Q4 2025), and -$1.36 (Q3 2025).